マルチエレクトロドカテーテルPFA: エネルギー用量変数による病変動態の計算モデルとインビボ検証
Xingkai Ji1, Kaihao Gu1, Hairui Wang1
1Department of Biomedical Engineering, School of Biomedical Engineering and Technology, Fudan University, Shanghai 200433, China.
Computer methods and programs in biomedicine
|August 23, 2025
まとめ
新しい連続放電モード (M2) は,従来の同時モード (M1) よりもパルスフィールドアブレーション (PFA) の有効性を大幅に改善します. このPFAの進歩は,制御された安全性プロファイルで病変の寸法と均一性を高めます.
科学分野:
- 医療機器
- 生物医学工学
- 電気生理学
背景:
- パルスフィールドアブレーション (PFA) は,固体腫瘍および心臓アブレーションのための非熱的方法である.
- PFAの有効性に影響する要因には,パルスパラメータ,キャセターの構成,および組織特性が含まれます.
- PFAの結果に対する異なる排出モードの影響は,まだ十分に研究されていない.
研究 の 目的:
- マルチエレクトロッド PFA カテーターの新しい連続放電モード (M2) を設計し評価する.
- 従来の同時放電モード (M1) と比べると,M2の消去効果と安全性を比較する.
- 放出モードが病変の特徴と筋肉の収縮に及ぼす影響を調査する.
主な方法:
- 連続放電モード (M2) は,マルチエレクトロッドアブレーションカテーテルのために開発されました.
- 数値シミュレーションと動物実験は,円形と線形カテーテル構成を用いて行われました.
- M1 と M2 の両方で,アブレーションの有効性,病変の大きさ,均一性,および筋肉の収縮が評価されました.
主要な成果:
- 連続放出モード (M2) は,両方のキャセタータイプにおける同時放出モード (M1) と比較して,より優れたアブレーション効果を示した.
- M2 傷口の最小の深さと傷口の深さの均一性が有意に改善された.
- M2は筋肉の収縮を わずかに引き起こす一方 両方のモードは 低い安全レベルを維持した.
結論:
- 連続放電モードは,高度なPFA戦略を表しています.
- このモードでは 病変の寸法と均一性が向上し 治療効果が向上します
- 連続的に排出されるPFAは,従来の方法と比較して良好な安全性プロファイルを維持しています.
関連する概念動画
01:17Factors Affecting Activity Coefficient
The extended Debye-Hückel equation indicates that the activity coefficient of an ion in an aqueous solution at 25°C depends on three partially interdependent properties: the ionic strength of the solution, the charge of the ion, and the ion size.
The activity coefficient value for an ion is close to one when the solution has almost zero ionic strength, i.e., when the solution shows close to ideal behavior. As the ionic strength of the solution increases from 0 to 0.1 mol/L, a decrease in the...
The activity coefficient value for an ion is close to one when the solution has almost zero ionic strength, i.e., when the solution shows close to ideal behavior. As the ionic strength of the solution increases from 0 to 0.1 mol/L, a decrease in the...
01:11One-Compartment Open Model: Urinary Excretion Data and Determination of k
The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also be...
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:13Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model
Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).